To assess the role of CD8+ cytotoxic T cells in the anti‐tumor activity of the combination treatment with APG‐157 and anti‐CTLA‐4 antibody, we performed depletion studies using anti‐CD8 antibody as shown in Figure 5A. This evidence concerns the gene CD8A and neoplasm.